P563: A RANDOMIZED, DOUBLE‐BLIND, 2‐ARM, MULTICENTER, PH3 STUDY OF VENETOCLAX & ORAL AZACITIDINE VS. ORAL AZACITIDINE AS MAINTENANCE THERAPY FOR PTS WITH AML IN FIRST REMISSION AFTER INTENSIVE CHEMOTHERAPHY

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; pp. 462 - 463
Main Authors Ivanov, V., Yeh, S.‐P., Mayer, J., Saini, L., Unal, A., Boyiadzis, M., Hoffman, D. M., Kang, K., Addo, S. N., Mendes, W. L., Fathi, A. T.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 01.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000845140.40137.c7